UroGen Pharma Ltd. (URGN)
$46.16-1.49%Close
BUYBULL · day 47
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $2.2B
- Avg volume
- 853.0K
- Beta
- 1.57
- P/E (TTM)
- -23.31
- Short % float
- 10.62%
- Days to cover
- 6.6
- SI change
- -19.3%
- 1W
- -6.06%
- 1M
- +12.67%
- 3M
- +59.78%
- YTD
- +103.26%
- vs SPY 1W
- -4.87%
- vs SPY 1M
- +9.35%
- vs SPY 3M
- +57.39%
- vs SPY YTD
- +91.50%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- SOPHBUYSOPHiA GENETICS S.A.BULLQ 2$8.45-2.31%
- PIIISELLP3 Health Partners Inc.CRISISQ -13$10.03-2.72%
- ADAPYSELLAdaptimmune Therapeutics plcCRISISQ -4$0.03+0.00%
- AGIOSELLAgios Pharmaceuticals, Inc.RECOVERYQ 4$32.64-1.36%
- LENZSELLLENZ Therapeutics, Inc.CRISISQ -25$4.59-1.92%
- PAVSBUYParanovus Entertainment Technology Ltd.CRISISQ -40$5.15+2.39%
- SYBXBUYSynlogic, Inc.RECOVERYQ -21$1.18-1.67%
- NSRXBUYNasus Pharma Ltd.RECOVERYQ -25$4.07+1.75%
- OGENBUYOragenics, Inc.RECOVERYQ -10$0.52-1.89%
- CLSDSELLClearside Biomedical, Inc.CRISISQ -15$0.25+0.00%
- MENSSELLJyong Biotech Ltd. Ordinary SharesRECOVERYQ -30$2.22+1.83%
- GERNBUYGeron CorporationRECOVERYQ 11$1.52+0.00%
Industry peers
FMP comparable companies · ranked by market cap
- TNGXSELLTango Therapeutics, Inc.$4.0BCRISISQ 24$24.51+2.64%
- NRIXBUYNurix Therapeutics, Inc.$2.7BBULLQ 13$26.27-1.68%
- KODSELLKodiak Sciences Inc.$2.3BCRISISQ 37$37.22-2.90%
- XNCRBUYXencor, Inc.$2.1BBULLQ 17$29.00+4.32%
- ANABBUYAnaptysBio, Inc.$1.7BRECOVERYQ 27$58.44+1.21%
- MNMDMind Medicine (MindMed) Inc.$1.6B$20.69
- OCSBUYOculis Holding AG$753MRECOVERYQ 5$13.18+0.69%
- BBOTBUYBridgeBio Oncology Therapeutics Inc.$732MRECOVERYQ 3$9.14+0.66%
- PHATSELLPhathom Pharmaceuticals, Inc.$701MCRISISQ 6$8.66-2.37%
- PROKSELLProKidney Corp.$541MRECOVERYQ 0$1.61+0.00%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 11
- VALUE
- 12
- GROWTH
- 15
- GARP
- 6
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC49.1%
REV YoY-
ROE81.8%
EPS YoY-
ROA-38.7%
GROSS91
OP-35
NET-52
[VALUATION]
P/E TTM-23.31
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B-17.57
P/FCF-
EV/EBITDA-33.46
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO3.80
ND/EBITDA-
BETA1.57
